![\"\"](\"https:\/\/www.heart-valve-surgery.com\/heart-surgery-blog\/..\/Images\/medtronic-ventilator-production.jpg\")
<\/p>\nAs the COVID-19 pandemic surges past 921,000 worldwide cases, I need to thank Medtronic for doubling its ventilator production to help patients suffering from the novel coronavirus.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
In our patient community, Medtronic is known for being an innovative manufacturer of heart valve replacement and repair devices. For example… After a successful clinical trial<\/a> in low-risk patients, Medtronic recently obtained FDA approval for its Evolut<\/a> device.\u00a0 Evolut is a non-invasive transcatheter aortic valve replacement (TAVR) device that treats aortic stenosis, a deadly form of heart disease, without open heart surgery.<\/p>\n <\/p>\n Specific to COVID-19, Medtronic is a leading manufacturer of ventilators (also known as breathing machines).\u00a0 Ventilators are critical for the treatment of COVID-19<\/a>.<\/p>\n Given the exponential rise of coronavirus patients, there is now a massive shortages of ventilators around the world.\u00a0 In New York City alone, which had 7,285 new cases yesterday, Governor Andrew Cuomo stated in a press conference<\/a> that he needs 30,000 ventilators to be prepared for the apex of new COVID-19 patients anticipated in the next two to three weeks.<\/p>\n That said, we cheered and applauded the news that Medtronic would increase its ventilator production by 100 percent to help patients with COVID-19.<\/p>\n To learn more about Medtronic’s proactive response to COVID-19, please watch this insightful video interview with Omar Ishrak, the CEO of Medtronic.\u00a0 Important topics covered in this video include the ventilator shortage, the different types of ventilators, a new Medtronic \/ Tesla partnership for ventilator production, multi-patient ventilator usage, the Defense Production Act, and more.<\/p>\n <\/p>\nMedtronic Responds to COVID-19 Outbreak<\/h2>\n